World Malaria Day — Developing antimalarials to save lives

25 Apr 2018

World Malaria Day is an internationally recognised day, highlighting the global efforts to control malaria and celebrating the gains that have been made. MMV-supported products have had significant impact and saved an estimated >1.5 million lives to date since 2009.

Learn more about these medicines and the lives they've impacted.

  • Photos: slide 1 - Novartis; slide 2 - Damien Schumann/MMV; slide 3 - Alena Koscalove/MSF; slide 4 - MMV; slide 5 - MAMaZ Against Malaria; slide 6 - Damien Schumann/MMV; slide 7 - Pierre Hugo/MMV; slide 8 - Pierre Hugo/MMV; slide 9 - Kolawole Maxwell/Malaria Consortium

    References:

    1. MMV estimates based on Novartis shipment data, national malaria indicator surveys and national disease burden.
    2. Dondorp AM et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 13;376(9753):1647-57 (2010) &
      Dondorp A et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 366(9487):717-25 (2005).